Vieillard, Vincent, 19..-....
Vincent Vieillard researcher
Vieillard, Vincent
VIAF ID: 296026768 (Personal)
Permalink: http://viaf.org/viaf/296026768
Preferred Forms
- 100 1 _ ‡a VIEILLARD, VINCENT.
- 100 1 _ ‡a Vieillard, Vincent
- 100 1 _ ‡a Vieillard, Vincent, ‡d 19..-....
- 100 0 _ ‡a Vincent Vieillard ‡c researcher
4xx's: Alternate Name Forms (1)
Works
Title | Sources |
---|---|
Accumulation of Intrahepatic TNF-α-Producing NKp44+ NK Cells Correlates With Liver Fibrosis and Viral Load in Chronic HCV Infection | |
B7-H6-mediated down-regulation of NKp30 in natural killer cells contributes to HIV-2 immune escape | |
CCR5 or CXCR4 use influences the relationship between CD4 cell depletion, NKp44L expression and NK cytotoxicity in SHIV-infected macaques | |
CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation | |
Cinétique des effecteurs immunologiques impliqués dans la protection contre le virus Herpès simplex type 1 (HSV1) après primo-infection par une autre souche non neurovirulente : vers un modèle vaccinal | |
CMV drives clonal expansion of NKG2C+ NK cells expressing self-specific KIRs in chronic hepatitis patients. | |
Constitutive expression of ligand for natural killer cell NKp44 receptor (NKp44L) by normal human articular chondrocytes. | |
Core/GC1QR interaction : to a new hepatic cells destruction mechanism by natural killer cells during hepatitis C virus chronical infection. | |
Etude des mécanismes régulateurs des cellules NK : rôle de la molécule PD-1 et de la prostaglandine E2 (PGE2) | |
Étude in vitro et ex vivo de la réponse des cellules dendritiques à l'infection par le virus Lassa | |
Expansion of CMV-mediated NKG2C+ NK cells associates with the development of specific de novo malignancies in liver-transplanted patients | |
Glycogen synthetase kinase 3 inhibition drives MIC-A/B to promote cytokine production by human natural killer cells in Dengue virus type 2 infection | |
The Hard Way towards an Antibody-Based HIV-1 Env Vaccine: Lessons from Other Viruses. | |
HIV escape from natural killer cytotoxicity: nef inhibits NKp44L expression on CD4+ T cells. | |
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial. | |
An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques | |
HLA-C-restricted viral epitopes are associated with an escape mechanism from KIR2DL2 NK cells in Lassa virus infection | |
Human NK cells display major phenotypic and functional changes over the life span | |
Identification of a cellular ligand for the natural cytotoxicity receptor NKp44. | |
Immunité muqueuse du VIH-1 : de l'infection à la prévention : la région conservée P1 de la protéine d'enveloppe gp41 du VIH-1 module la réponse muqueuse innée et agit en tant qu'adjuvant muqueux. | |
Immunogenetic and immuno-inflammatory characteristics of autism spectrum disorders (ASD). | |
Impact des cellules NK dans le traitement de la Leucémie Lymphoïde Chronique et de la maladie de Waldenström par anticorps anti-CD20 optimisés | |
Impact of TET2/IDH mutations on lymphocytes populations of myelodysplastic syndromes. | |
Implication des cellules Natural Killer dans la physiopathologie des infections chroniques VIH et VHC : application à des stratégies thérapeutiques | |
Implication of NK cells in auto-immune diseases. | |
Interaction de la protéine de capside Core du VHC avec le gC1qR : vers un nouveau mécanisme de destruction hépatocytaire par les cellules NK au cours de l'infection chronique par le VHC | |
Involvement of NK cells in the physiopathology of HIV and HCV chronic infections : Input in therapeutic strategies. | |
Kinetics of immune effectors involved in protection against HSV1 after a primary infection by a non-virulent strain : toward a vaccinal model. | |
Longitudinal Analysis of Natural Killer Cells in Dengue Virus-Infected Patients in Comparison to Chikungunya and Chikungunya/Dengue Virus-Infected Patients | |
Mécanisme de transmission de signal viral immunostimulateur des cellules infectés aux cellules dendritiques plasmacytoïdes par contacts cellulaires. | |
Metastatic tumors immunosurveillance by innate lymphoid cells. | |
Molecularly Imprinted Polymer Nanoparticles as Potential Synthetic Antibodies for Immunoprotection against HIV | |
Natural killer cell deficiency in patients with non-Hodgkin lymphoma after lung transplantation | |
Natural Killer Lymphocytes Are Dysfunctional in Kidney Transplant Recipients on Diagnosis of Cancer | |
Neutralizing Antibodies Against a Specific Human Immunodeficiency Virus gp41 Epitope are Associated With Long-term Non-progressor Status | |
New approaches to multiparametric analysis in mass cytometry. | |
NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect | |
NK Cell Responses in Zika Virus Infection Are Biased towards Cytokine-Mediated Effector Functions | |
NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs | |
NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand | |
NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells | |
NKp44L: A new tool for fighting cancer | |
NKp44L expression on CD4+ T cells is associated with impaired immunological recovery in HIV-infected patients under highly active antiretroviral therapy | |
Les nouvelles approches de l'analyse multi-paramétrique en cytométrie de masse : caractérisation des cellules réservoirs du VIH | |
Optimization of the EC26-2A4 epitope in the gp41 membrane proximal external region (MPER) targeted by neutralizing antibodies from an elite controller | |
Persistence of CD16+/CD56−/2B4+ natural killer cells: A highly dysfunctional NK subset expanded in ocular myasthenia gravis | |
Persistence of dysfunctional natural killer cells in adults with high-functioning autism spectrum disorders: stigma/consequence of unresolved early infectious events? | |
Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | |
Perspectives for immunotherapy: which applications might achieve an HIV functional cure? | |
Phenotype and function of natural killer cells in systemic lupus erythematosus: Excess interferon-γ production in patients with active disease | |
A polysaccharide virulence factor of a human fungal pathogen induces neutrophil apoptosis via NK cells | |
Pregnancy-related immunological issues in two models : uterine transplantation and SARS-CoV-2 infection. | |
Regulation of NK cells immune response : role of PD-1 and PGE2. | |
Réponse antivirale des cellules dendritiques plasmacytoides contre des cellules infectées via la formation d'une synapse interferogénique | |
Research of Interactors of the Immunosuppressive Domain of Retroviral Envelope Proteins. | |
Reverse Immunology Approach to Define a New HIV-gp41-Neutralizing Epitope | |
Rôle des cellules natural killer dans la transmission mère-foetus du virus Zika | |
Shaping of iNKT cell repertoire after unrelated cord blood transplantation. | |
A single amino-acid change in a highly conserved motif of gp41 elicits HIV-1 neutralization and protects against CD4 depletion. | |
Specific adaptive humoral response against a gp41 motif inhibits CD4 T-cell sensitivity to NK lysis during HIV-1 infection | |
Specific anti-gp41 antibodies predict HIV-1 disease progression | |
Specific phenotypic and functional features of natural killer cells from HIV-infected long-term nonprogressors and HIV controllers | |
Towards a vaccine against HIV: antibodies raised by a gp41 peptide neutralize the virus and inhibit pathogenesis | |
Transplantation-induced cancers: Emerging evidence that clonal CMV-specific NK cells are causal immunogenic factors | |
Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity | |
Viremic HIV infected individuals with high CD4 T cells and functional envelope proteins show anti-gp41 antibodies with unique specificity and function |